| Dissecting effects of anti-cancer drugs and cancer-associated fibroblasts by on-chip reconstitution of immunocompetent tumor microenvironments M Nguyen, A De Ninno, A Mencattini, F Mermet-Meillon, G Fornabaio, ... Cell reports 25 (13), 3884-3893. e3, 2018 | 139 | 2018 |
| Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature ME Gilles, F Maione, M Cossutta, G Carpentier, L Caruana, S Di Maria, ... Cancer research 76 (24), 7181-7193, 2016 | 113 | 2016 |
| The extracellular matrix in pancreatic cancer: description of a complex network and promising therapeutic options B Ferrara, C Pignatelli, M Cossutta, A Citro, J Courty, L Piemonti Cancers 13 (17), 4442, 2021 | 54 | 2021 |
| Weibel-palade bodies orchestrate pericytes during angiogenesis M Cossutta, M Darche, G Carpentier, C Houppe, M Ponzo, F Raineri, ... Arteriosclerosis, thrombosis, and vascular biology 39 (9), 1843-1858, 2019 | 28 | 2019 |
| Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy Z Diamantopoulou, ME Gilles, M Sader, M Cossutta, B Vallée, C Houppe, ... Oncotarget 8 (52), 90108, 2017 | 16 | 2017 |
| Polymerization-Induced Self-Assembly (PISA) for in situ drug encapsulation or drug conjugation in cancer application H Phan, M Cossutta, C Houppe, C Le Cœur, S Prevost, I Cascone, ... Journal of Colloid and Interface Science 618, 173-184, 2022 | 14 | 2022 |
| Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies M Darche, M Cossutta, L Caruana, C Houppe, ME Gilles, D Habert, ... The FASEB Journal 34 (4), 5851-5862, 2020 | 12 | 2020 |
| Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression M Ponzo, A Debesset, M Cossutta, M Chalabi-Dchar, C Houppe, C Pilon, ... Cancers 14 (17), 4265, 2022 | 6 | 2022 |
| N6L-functionalized nanoparticles for targeted and inhibited pancreatic cancer cells S Belbekhouche, M Cossutta, D Habert, S Hamadi, T Modjinou, I Cascone, ... Colloids and Surfaces A: Physicochemical and Engineering Aspects 607, 125461, 2020 | 5 | 2020 |
| Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma F Raineri, S Bourgoin-Voillard, M Cossutta, D Habert, M Ponzo, ... Cancers 13 (12), 2986, 2021 | 4 | 2021 |
| Etude et inhibition de l'activation endothéliale au cours de l'angiogenèse M Cossutta Médecine humaine et pathologie. Université Paris-Est, 2017 | 1 | 2017 |
| Digital Image Analysis-Aided Assessment of HER2 Immunohistochemistry for External Proficiency Testing R Røge, M Cossutta, HL Kristoffersen, E Tatarinova, A Papine, ... Laboratory Investigation 103 (Suppl. 3), 2023 | | 2023 |
| Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265 M Ponzo, A Debesset, M Cossutta, M Chalabi-Dchar, C Houppe, C Pilon, ... Cancers 14 (24), 6160, 2022 | | 2022 |
| Apports de l’analyse d’image automatisée à la quantification de Ki67 dans le cancer du sein–Expérience issue du test AFAQAP 2021 avec 55 participants M Cossutta, A Papine, C Homsy, M Soussaline, C Egele, JP BELLOCQ, ... Annales de Pathologie 42 (5), 410-411, 2022 | | 2022 |
José CourtyUpec CNRS在 u-pec.fr 的电子邮件经过验证
